Results 201 to 207 of about 1,348,486 (207)
Some of the next articles are maybe not open access.
Clinical characteristics of and risk factors for serious infection in Japanese patients within six months of remission induction therapy for antineutrophil cytoplasmic antibody-associated vasculitis registered in a nationwide, prospective, inception cohort study
Modern Rheumatology, 2017 Kaori Watanabe-Imai, M. Harigai, K. Sada, M. Yamamura, T. Fujii, H. Dobashi, K. Amano, S. Ito, S. Homma, S. Kumagai, S. Banno, Y. Arimura, H. Makino +12 moresemanticscholar +1 more sourceEffectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial
Annals of the Rheumatic Diseases, 2016 P. Verschueren, D. De Cock, L. Corluy, R. Joos, C. Langenaken, V. Taelman, F. Raeman, I. Ravelingien, K. Vandevyvere, J. Lenaerts, E. Geens, P. Geusens, J. Vanhoof, A. Durnez, J. Remans, B. Vander Cruyssen, E. Van Essche, A. Sileghem, G. De Brabanter, J. Joly, S. Meyfroidt, K. Van der Elst, R. Westhovens +22 moresemanticscholar +1 more sourceEfficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease—the Israeli Real-World Experience
Inflammatory Bowel Diseases, 2017 U. Kopylov, Y. Ron, I. Avni-Biron, B. Koslowsky, M. Waterman, S. Daher, B. Ungar, H. Yanai, N. Maharshak, O. Ben-Bassat, L. Lichtenstein, A. Bar-Gil Shitrit, E. Israeli, D. Schwartz, E. Zittan, R. Eliakim, Y. Chowers, S. Ben-Horin, I. Dotan +18 moresemanticscholar +1 more sourceAzithromycin and metronidazole versus metronidazole-based therapy for the induction of remission in mild to moderate paediatric Crohn’s disease : a randomised controlled trial
Gut, 2018 A. Levine, M. Kori, J. Kierkuś, R. Sigall Boneh, M. Sładek, J. Escher, E. Wine, B. Yerushalmi, J. Amil Dias, R. Shaoul, G. Veereman Wauters, M. Boaz, G. Abitbol, A. Bousvaros, D. Turner +14 moresemanticscholar +1 more sourceTocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial
The Lancet, 2016 P. Villiger, S. Adler, S. Kuchen, F. Wermelinger, D. Dan, Veronika Fiege, L. Bütikofer, M. Seitz, S. Reichenbach +8 moresemanticscholar +1 more source
